相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
Abigail Kora Suwala et al.
Oncotarget (2018)
Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor
Jeewon Kim et al.
ONCOTARGET (2017)
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
Hong-Quan Duong et al.
ANTIOXIDANTS (2017)
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Geraldine Gentric et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein
Chengyong Dong et al.
ONCOTARGET (2016)
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer
Beomseok Son et al.
SCIENTIFIC REPORTS (2016)
Dysregulated metabolism contributes to oncogenesis
Matthew D. Hirschey et al.
SEMINARS IN CANCER BIOLOGY (2015)
1-Dodecyl-3-Methylimidazolium Chloride-Assisted Sample Preparation Method for Efficient Integral Membrane Proteome Analysis
Qun Zhao et al.
ANALYTICAL CHEMISTRY (2014)
Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
Jennifer A. McAlpine et al.
BMC CANCER (2014)
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 ( ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity
Bibek Parajuli et al.
CHEMBIOCHEM (2014)
Selective ALDH3A1 Inhibition by Benzimidazole Analogues Increase Mafosfamide Sensitivity in Cancer Cells
Bibek Parajuli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Enhanced FASP (eFASP) to Increase Proteome Coverage and Sample Recovery for Quantitative Proteomic Experiments
Jonathan Erde et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Mass Defect-Based Pseudo-Isobaric Dimethyl Labeling for Proteome Quantification
Yuan Zhou et al.
ANALYTICAL CHEMISTRY (2013)
FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
L. Cheng et al.
CELL DEATH & DISEASE (2013)
Targeting cellular metabolism to improve cancer therapeutics
Y. Zhao et al.
CELL DEATH & DISEASE (2013)
Establishment and characterization of two 5-fluorouracil-resistant hepatocellular carcinoma cell lines
Kazuya Uchibori et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line
Shi-Wen Tong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
Uzma Asghar et al.
JOURNAL OF HEPATOLOGY (2012)
Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers
Toshiyuki Matsunaga et al.
FRONTIERS IN PHARMACOLOGY (2012)
Octamer 4 (Oct4) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct4-AKT-ATP-Binding Cassette G2 Pathway
Xiao Qi Wang et al.
HEPATOLOGY (2010)
Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry
Hui-Min Zhang et al.
PROTEIN SCIENCE (2010)
Universal sample preparation method for proteome analysis
Jacek R. Wisniewski et al.
NATURE METHODS (2009)
Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Massimo Di Maio et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
The functions and structure of ABC transporters: Implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR)
E. Teodori et al.
CURRENT DRUG TARGETS (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
分享论文
